The Synthesis and Characterization of a Delivery System Based on Polymersomes and a Xanthone with Inhibitory Activity in Glioblastoma.

Bibliographic Details
Title: The Synthesis and Characterization of a Delivery System Based on Polymersomes and a Xanthone with Inhibitory Activity in Glioblastoma.
Authors: Alves, Ana1,2,3 (AUTHOR), Silva, Ana Margarida4 (AUTHOR), Nunes, Claúdia5 (AUTHOR), Cravo, Sara2,6 (AUTHOR), Reis, Salette5 (AUTHOR), Pinto, Madalena2,6 (AUTHOR), Sousa, Emília2,6 (AUTHOR), Rodrigues, Francisca4 (AUTHOR), Ferreira, Domingos1,3 (AUTHOR), Costa, Paulo C.1,3 (AUTHOR) pccosta@ff.up.pt, Correia-da-Silva, Marta2,6 (AUTHOR) pccosta@ff.up.pt
Source: Life (2075-1729). Jan2024, Vol. 14 Issue 1, p132. 17p.
Subject Terms: *XANTHONE, *POLYMERSOMES, *GLIOBLASTOMA multiforme, *BRAIN tumors, *ETHYLENE glycol, *CYTOTOXINS, *POLYCAPROLACTONE
Abstract: Glioblastoma (GBM) is the most common and deadly primary malignant brain tumor. Current therapies are insufficient, and survival for individuals diagnosed with GBM is limited to a few months. New GBM treatments are urgent. Polymeric nanoparticles (PNs) can increase the circulation time of a drug in the brain capillaries. Polymersomes (PMs) are PNs that have been described as having attractive characteristics, mainly due to their stability, prolonged circulation period, biodegradability, their ability to sustain the release of drugs, and the possibility of surface functionalization. In this work, a poly(ethylene glycol)-ε-caprolactone (PEG-PCL) copolymer was synthesized and PMs were prepared and loaded with an hydrolytic instable compound, previously synthesized by our research team, the 3,6-bis(2,3,4,6-tetra-O-acetyl-β-glucopyranosyl)xanthone (XGAc), with promising cytotoxicity on glioblastoma cells (U-373 MG) but also on healthy cerebral endothelial cells (hCMEC/D3). The prepared PMs were spherical particles with uniform morphology and similar sizes (mean diameter of 200 nm) and were stable in aqueous suspension. The encapsulation of XGAc in PMs (80% encapsulation efficacy) protected the healthy endothelial cells from the cytotoxic effects of this compound, while maintaining cytotoxicity for the glioblastoma cell line U-373 MG. Our studies also showed that the prepared PMs can efficiently release XGAc at intratumoral pHs. [ABSTRACT FROM AUTHOR]
Copyright of Life (2075-1729) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
More Details
ISSN:20751729
DOI:10.3390/life14010132
Published in:Life (2075-1729)
Language:English